Jim Cramer Says “Cardinal Is Really the Monster” Among Drug Distributors

Group 1 - Cardinal Health, Inc. (NYSE:CAH) is recognized as a leading player among U.S. drug distributors, with a significant performance increase of over 40% last year [1][2] - The company benefits from rising demand for complex specialty and biologic therapies, expanding its value-added service offerings [2] - Cardinal Health is involved in adjacent markets such as third-party logistics and nuclear medicine, indicating diversification in its business model [2] Group 2 - The medical distribution business of Cardinal Health is undergoing a turnaround, with new management making progress in improving service gaps and margins [2] - Despite the positive outlook for Cardinal Health, some analysts suggest that certain AI stocks may present greater upside potential and lower downside risk [2]